Previous Article | Next Article ![]()
Journal of Virology, March 2000, p. 2731-2739, Vol. 74, No. 6
Departments of
Immunology1 and Cell
Biology,2 The Scripps Research Institute, La
Jolla, California 92037
Received 30 September 1999/Accepted 21 December 1999
Adenovirus (Ad) cell entry involves sequential interactions with
host cell receptors that mediate attachment (CAR), internalization (
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Regulation of Adenovirus Membrane Penetration by
the Cytoplasmic Tail of Integrin
5
v
3 and
v
5), and penetration (
v
5) of the endosomal
membrane. These events allow the virus to deliver its genome to the
nucleus. While integrins
v
3 and
v
5 both promote Ad
internalization into cells, integrin
v
5 selectively facilitates
Ad-mediated membrane permeabilization and endosome rupture. In the
experiments reported herein, we demonstrate that the intracellular
domain of the integrin
5 subunit specifically regulates Ad-mediated membrane permeabilization and gene delivery. CS-1 melanoma cells expressing a truncated integrin
5 or a chimeric (
5-
3)
cytoplasmic tail (CT) supported normal levels of Ad endocytosis but had
reduced Ad-mediated gene delivery and membrane permeabilization
relative to cells expressing a wild-type integrin
5. Thin-section
electron microscopy revealed that virion particles were capable of
being endocytosed into cells expressing a truncated
5CT, but they
failed to escape cytoplasmic vesicles and translocate to the nucleus. Site-specific mutagenesis studies suggest that a C-terminal TVD motif
in the
5CT plays a major role in Ad membrane penetration.
*
Corresponding author. Mailing address: Department of
Immunology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 784-8072. Fax: (858) 784-8472. E-mail:
gnemerow{at}scripps.edu.
Manuscript 12502-IMM of The Scripps Research Institute.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|